Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.0K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.0K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

790
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
790
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

920
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
920
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

7.5K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
7.5K
Focusing of Light in the Eye01:16

Focusing of Light in the Eye

3.7K
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
3.7K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

52
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
52

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Flip Sides of Interventional Glaucoma.

Ophthalmology. Glaucoma·2026
Same author

Accuracy and Readability of Chat Generative Pre-Trained Transformer-4 Omni in Answering Ophthalmology Patient Questions.

Ophthalmology science·2026
Same author

A Blurry Bottom Line: The Economics of Declining Medicare Payment Trends in Ophthalmology Subspecialties, 2003 to 2024.

Inquiry : a journal of medical care organization, provision and financing·2025
Same author

Association of Social Determinants of Health With the Likelihood of Treatment With Laser Trabeculoplasty in a US Database.

Journal of glaucoma·2024
Same author

Intraluminal Suture Placement for Management of Hypotony After Glaucoma Drainage Device Surgery.

Journal of glaucoma·2024
Same author

Incidence and Outcomes of Hypertensive Phase After Glaucoma Drainage Device Surgery.

Ophthalmology. Glaucoma·2024

Related Experiment Video

Updated: Nov 7, 2025

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.3K

Glaucoma.

Jessica Minjy Kang1, Angelo P Tanna1

  • 1Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

The Medical Clinics of North America
|April 30, 2021
PubMed
Summary
This summary is machine-generated.

Glaucoma is a leading cause of irreversible blindness, affecting 3.5% of adults aged 40-80. Early diagnosis and lifelong management are crucial for preventing vision loss, as current treatments cannot reverse existing damage.

Keywords:
Angle-closure glaucomaGlaucomaGlaucoma treatmentOpen-angle glaucomaSecondary glaucoma

More Related Videos

Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

12.4K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.6K

Related Experiment Videos

Last Updated: Nov 7, 2025

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.3K
Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

12.4K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.6K

Area of Science:

  • Ophthalmology
  • Public Health

Background:

  • Glaucoma is the primary cause of irreversible blindness globally.
  • Affects an estimated 3.5% of individuals aged 40-80.
  • Projected to impact 111.8 million people by 2040 due to an aging population.

Purpose of the Study:

  • To provide a comprehensive review of glaucoma.
  • To cover pathophysiology, classification, clinical manifestations, diagnosis, and management.

Main Methods:

  • Literature review of glaucoma studies.
  • Synthesis of current knowledge on glaucoma.

Main Results:

  • Glaucoma necessitates lifelong management.
  • Early detection and treatment are key to preventing disease progression.
  • Current therapies do not reverse established visual system damage.

Conclusions:

  • Glaucoma is a significant global health challenge requiring ongoing management.
  • Understanding pathophysiology, diagnosis, and management is vital for patient care.